APLT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $6,057,776.69

Applied Therapeutics Insider Trading History Chart

Applied Therapeutics Share Price & Price History

^$0.50

▼ -0.0227 (-4.35%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Applied Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/4/2025	Riccardo Perfetti	Insider	Sell	10,366	$0.44	$4,561.04	890,409
2/6/2025	Leslie D Funtleyder	Insider	Sell	22,950	$0.61	$13,999.50	404,961
8/14/2024	Shoshana Shendelman	CEO	Sell	119,591	$5.93	$709,174.63	4,690,839
8/12/2024	Shoshana Shendelman	CEO	Sell	300,000	$5.98	$1,794,000.00	5,167,853
6/6/2024	Leslie D Funtleyder	CFO	Sell	16,980	$4.32	$73,353.60	291,441
6/6/2024	Riccardo Perfetti	Insider	Sell	22,003	$4.32	$95,052.96	1,009,534
6/6/2024	Shoshana Shendelman	CEO	Sell	61,795	$4.32	$266,954.40	3,756,019
6/4/2024	Real Estate Equitie Alexandria	Major Shareholder	Sell	150,000	$4.21	$631,500.00	6,005,077
3/14/2024	Leslie D Funtleyder	CFO	Sell	28,727	$5.39	$154,838.53	308,421
3/14/2024	Riccardo Perfetti	Insider	Sell	110,804	$5.39	$597,233.56	1,031,537
3/14/2024	Shoshana Shendelman	CEO	Sell	318,573	$5.39	$1,717,108.47	3,817,814
12/1/2023	Stacy J Kanter	Director	Buy	30,000	$2.18	$65,400.00	63,000
11/30/2023	Riccardo Perfetti	Insider	Sell	1,583	$1.97	$3,118.51	692,341
11/30/2023	Shoshana Shendelman	CEO	Sell	3,968	$1.97	$7,816.96	2,596,387
11/2/2023	Real Estate Equitie Alexandria	Major Shareholder	Sell	103,808	$2.32	$240,834.56	5,723,527
10/31/2023	Real Estate Equitie Alexandria	Major Shareholder	Sell	155,000	$2.41	$373,550.00	6,000,077
9/27/2023	Riccardo Perfetti	Insider	Sell	10,932	$2.70	$29,516.40	693,924
9/27/2023	Shoshana Shendelman	CEO	Sell	115,632	$2.70	$312,206.40	2,600,355
1/11/2023	Riccardo Perfetti	Insider	Sell	6,053	$0.91	$5,508.23	154,856
1/11/2023	Shoshana Shendelman	CEO	Sell	15,870	$0.91	$14,441.70	751,625
10/14/2022	Shoshana Shendelman	CEO	Buy	50,000	$0.65	$32,500.00	767,495
10/12/2022	Shoshana Shendelman	CEO	Buy	38,153	$0.52	$19,839.56	644,239
6/27/2022	Real Estate Equitie Alexandria	Major Shareholder	Buy	3,500,000	$1.00	$3,500,000.00	4,555,077
5/16/2022	Chids Mahadevan	Insider	Sell	905	$1.65	$1,493.25	9,800
3/23/2022	Riccardo Perfetti	Insider	Buy	30,000	$1.97	$59,100.00
3/21/2022	Riccardo Perfetti	Insider	Buy	12,548	$1.85	$23,213.80

See Full Table

SEC Filings (Institutional Ownership Changes) for Applied Therapeutics (NASDAQ:APLT)

98.31% of Applied Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Applied Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/27/2025	Jefferies Financial Group Inc.	276,700	$0.24M	0.0%	N/A	0.238%
2/18/2025	Knoll Capital Management LLC	5,799,687	$4.97M	3.2%	+4.0%	4.984%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	119,035	$0.10M	0.0%	N/A	0.102%
2/17/2025	VR Adviser LLC	9,990,591	$8.55M	0.6%	+1.7%	8.586%
2/17/2025	Windsor Advisory Group LLC	416,757	$0.36M	0.4%	+109.4%	0.358%
2/17/2025	Vestal Point Capital LP	11,500,000	$9.85M	0.6%	+904.4%	9.883%
2/17/2025	Two Sigma Investments LP	293,810	$0.25M	0.0%	N/A	0.253%
2/17/2025	Tang Capital Management LLC	2,428,169	$2.08M	0.1%	-11.1%	2.087%
2/17/2025	Toronto Dominion Bank	32,000	$27K	0.0%	N/A	0.028%
2/17/2025	Sphera Funds Management LTD.	50,000	$43K	0.0%	-84.0%	0.043%
2/17/2025	Nuveen Asset Management LLC	281,028	$0.24M	0.0%	+7.5%	0.242%
2/17/2025	Millennium Management LLC	1,329,149	$1.14M	0.0%	+252.2%	1.142%
2/17/2025	Janus Henderson Group PLC	35,791	$31K	0.0%	-99.7%	0.031%
2/17/2025	Jefferies Financial Group Inc.	276,700	$0.24M	0.0%	N/A	0.238%
2/17/2025	Ground Swell Capital LLC	31,636	$27K	0.0%	N/A	0.027%
2/17/2025	Deutsche Bank AG	4,468,122	$3.84M	0.0%	+0.7%	3.840%
2/17/2025	Bank of America Corp DE	167,415	$0.14M	0.0%	-46.8%	0.144%
2/17/2025	BNP Paribas Financial Markets	174,651	$0.15M	0.0%	+29.1%	0.150%
2/17/2025	Alyeska Investment Group L.P.	2,707,497	$2.32M	0.0%	+175.8%	2.327%
2/14/2025	Schonfeld Strategic Advisors LLC	8,762,291	$7.50M	0.0%	+2,458.3%	7.530%
2/14/2025	Tudor Investment Corp ET AL	57,454	$49K	0.0%	N/A	0.049%
2/14/2025	Propel Bio Management LLC	9,615,420	$8.23M	8.2%	+46.4%	8.264%
2/14/2025	Adage Capital Partners GP L.L.C.	1,961,629	$1.68M	0.0%	-52.3%	1.686%
2/14/2025	Price T Rowe Associates Inc. MD	34,763	$30K	0.0%	-96.6%	0.030%
2/14/2025	T. Rowe Price Investment Management Inc.	5,420,920	$4.64M	0.0%	+2,511.9%	4.659%
2/14/2025	Dark Forest Capital Management LP	53,718	$46K	0.0%	+54.5%	0.046%
2/14/2025	Rock Springs Capital Management LP	1,917,191	$1.64M	0.1%	+9.8%	1.648%
2/13/2025	Marshall Wace LLP	1,307,381	$1.12M	0.0%	+144.8%	1.124%
2/13/2025	XTX Topco Ltd	173,568	$0.15M	0.0%	+178.0%	0.149%
2/13/2025	Barclays PLC	172,015	$0.15M	0.0%	-14.0%	0.148%
2/13/2025	Legal & General Group Plc	84,018	$72K	0.0%	+293.9%	0.072%
2/13/2025	Invesco Ltd.	53,499	$46K	0.0%	-90.4%	0.046%
2/13/2025	Aristides Capital LLC	156,507	$0.13M	0.0%	N/A	0.135%
2/12/2025	Franklin Resources Inc.	2,003,400	$1.72M	0.0%	-70.5%	1.722%
2/12/2025	Wellington Management Group LLP	237,850	$0.20M	0.0%	+17.8%	0.204%
2/12/2025	Norges Bank	243,200	$0.21M	0.0%	N/A	0.209%
2/11/2025	Intech Investment Management LLC	52,631	$45K	0.0%	+176.1%	0.045%
2/10/2025	Swiss National Bank	146,900	$0.13M	0.0%	N/A	0.126%
2/6/2025	Charles Schwab Investment Management Inc.	700,836	$0.60M	0.0%	-4.7%	0.602%
2/3/2025	Private Advisor Group LLC	40,300	$35K	0.0%	N/A	0.035%
1/17/2025	SG Americas Securities LLC	40,747	$35K	0.0%	+169.0%	0.035%
1/15/2025	Hennion & Walsh Asset Management Inc.	313,355	$0.27M	0.0%	+18.1%	0.269%
11/27/2024	Franklin Resources Inc.	6,800,910	$60.46M	0.0%	-33.4%	5.845%
11/19/2024	Barclays PLC	200,012	$1.70M	0.0%	+186.1%	0.172%
11/16/2024	Geode Capital Management LLC	2,091,669	$17.78M	0.0%	-0.3%	1.798%
11/15/2024	Barclays PLC	200,012	$1.70M	0.0%	+186.1%	0.172%
11/15/2024	Y Intercept Hong Kong Ltd	17,542	$0.15M	0.0%	N/A	0.015%
11/15/2024	XTX Topco Ltd	62,440	$0.53M	0.0%	N/A	0.054%
11/15/2024	Wellington Management Group LLP	201,966	$1.72M	0.0%	N/A	0.174%
11/15/2024	Sphera Funds Management LTD.	311,572	$2.65M	0.4%	-53.8%	0.268%
11/15/2024	State Street Corp	3,694,607	$31.40M	0.0%	+123.1%	3.175%
11/15/2024	Parkman Healthcare Partners LLC	907,294	$7.71M	1.0%	-21.0%	0.780%
11/15/2024	Janus Henderson Group PLC	10,541,528	$89.66M	0.0%	+37.8%	9.059%
11/14/2024	Vestal Point Capital LP	1,145,000	$9.73M	0.7%	-78.9%	0.984%
11/14/2024	Walleye Capital LLC	137,593	$1.17M	0.0%	-65.8%	0.118%
11/14/2024	Ally Bridge Group NY LLC	618,332	$5.26M	2.8%	N/A	0.531%
11/14/2024	MetLife Investment Management LLC	56,302	$0.48M	0.0%	+129.1%	0.048%
11/13/2024	BNP Paribas Financial Markets	135,272	$1.15M	0.0%	+1,855.1%	0.116%
11/13/2024	The Manufacturers Life Insurance Company	123,725	$1.05M	0.0%	+236.0%	0.106%
11/12/2024	Charles Schwab Investment Management Inc.	735,217	$6.25M	0.0%	+165.2%	0.640%
11/9/2024	Intech Investment Management LLC	19,064	$0.16M	0.0%	N/A	0.017%
10/23/2024	Hennion & Walsh Asset Management Inc.	265,372	$2.26M	0.1%	+34.7%	0.232%
10/3/2024	SG Americas Securities LLC	15,146	$0.13M	0.0%	-18.4%	0.013%
8/27/2024	Logos Global Management LP	600,000	$2.66M	0.2%	-55.6%	0.525%
8/16/2024	Perceptive Advisors LLC	8,005,000	$37.38M	0.9%	-5.9%	7.006%
8/16/2024	Algert Global LLC	23,476	$0.11M	0.0%	N/A	0.021%
8/16/2024	Frazier Life Sciences Management L.P.	2,286,135	$10.68M	0.5%	+17.1%	2.001%
8/15/2024	The Manufacturers Life Insurance Company	36,824	$0.17M	0.0%	N/A	0.032%
8/14/2024	Logos Global Management LP	600,000	$2.66M	0.2%	-55.6%	0.525%
8/13/2024	Sei Investments Co.	114,619	$0.54M	0.0%	N/A	0.100%
8/12/2024	Marathon Trading Investment Management LLC	15,907	$74K	0.0%	-73.0%	0.014%
8/5/2024	Victory Capital Management Inc.	11,494	$54K	0.0%	N/A	0.010%
8/1/2024	Rhumbline Advisers	133,895	$0.63M	0.0%	+24,513.1%	0.117%
7/29/2024	Peregrine Capital Management LLC	731,048	$3.41M	0.1%	N/A	0.640%
7/29/2024	Principal Financial Group Inc.	11,583	$54K	0.0%	N/A	0.010%
7/26/2024	Bank of New York Mellon Corp	283,793	$1.33M	0.0%	N/A	0.248%
7/20/2024	Hennion & Walsh Asset Management Inc.	197,042	$0.92M	0.0%	N/A	0.172%
7/12/2024	SG Americas Securities LLC	18,567	$87K	0.0%	N/A	0.016%
5/29/2024	Opaleye Management Inc.	1,770,000	$12.04M	2.6%	+62.0%	1.549%
5/17/2024	Artal Group S.A.	1,009,500	$6.87M	0.2%	N/A	0.883%
5/16/2024	Janus Henderson Group PLC	6,414,642	$43.56M	0.0%	+198.6%	5.614%
5/16/2024	Knoll Capital Management LLC	5,574,687	$37.91M	23.6%	+1.8%	4.879%
5/15/2024	Altitude Crest Partners Inc.	259,700	$1.77M	0.8%	N/A	0.227%
5/14/2024	EntryPoint Capital LLC	40,070	$0.27M	0.2%	N/A	0.035%
5/14/2024	StemPoint Capital LP	2,017,016	$13.72M	3.6%	+122.3%	1.765%
5/14/2024	Propel Bio Management LLC	6,111,906	$41.56M	23.1%	+13.7%	5.349%
5/10/2024	Vanguard Group Inc.	3,010,290	$20.47M	0.0%	-6.8%	2.635%
5/10/2024	Richmond Brothers Inc.	61,827	$0.42M	0.8%	-50.0%	0.054%
5/7/2024	Susquehanna Portfolio Strategies LLC	14,099	$96K	0.0%	-43.8%	0.012%
4/19/2024	Denali Advisors LLC	33,600	$0.23M	0.1%	N/A	0.032%
2/15/2024	Opaleye Management Inc.	1,092,500	$3.66M	1.0%	+22.3%	1.415%
2/15/2024	Parkman Healthcare Partners LLC	1,019,156	$3.41M	0.5%	-41.8%	1.320%
2/14/2024	Vestal Point Capital LP	4,155,000	$13.92M	1.5%	N/A	5.380%
2/13/2024	Tower Research Capital LLC TRC	23,175	$78K	0.0%	-34.6%	0.030%
2/12/2024	AIGH Capital Management LLC	1,659,039	$5.56M	2.2%	+109.1%	2.148%
2/9/2024	Worth Venture Partners LLC	412,981	$1.38M	0.7%	+112.9%	0.535%
2/9/2024	Franklin Resources Inc.	7,017,912	$23.51M	0.0%	-11.7%	9.087%
2/7/2024	Jump Financial LLC	24,171	$81K	0.0%	N/A	0.031%
1/30/2024	Vontobel Holding Ltd.	10,000	$34K	0.0%	N/A	0.013%
12/6/2023	Citigroup Inc.	65,976	$0.16M	0.0%	N/A	0.085%

Data available starting January 2016

See Full Table

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Today's Range

Now: $0.50

$0.49

$0.53

50 Day Range

MA: $0.60

$0.46

$0.94

52 Week Range

Now: $0.50

$0.43

$10.62

Volume

1,194,510 shs

Average Volume

4,066,573 shs

Market Capitalization

$58.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.88

Who are the company insiders with the largest holdings of Applied Therapeutics?: Applied Therapeutics' top insider shareholders include:
Real Estate Equitie Alexandria (Major Shareholder)
Shoshana Shendelman (CEO)
Riccardo Perfetti (Insider)
Leslie D Funtleyder (Insider)
Leslie D Funtleyder (CFO)
Stacy J Kanter (Director)
Learn More about top insider investors at Applied Therapeutics.
Who are the major institutional investors of Applied Therapeutics?: Applied Therapeutics' top institutional investors include:
Vestal Point Capital LP — 9.88%
VR Adviser LLC — 8.59%
Propel Bio Management LLC — 8.26%
Schonfeld Strategic Advisors LLC — 7.53%
Knoll Capital Management LLC — 4.98%
T. Rowe Price Investment Management Inc. — 4.66%
Learn More about top institutional investors of Applied Therapeutics stock.
Which major investors are selling Applied Therapeutics stock?: In the previous quarter, APLT stock was sold by these institutional investors:
Janus Henderson Group PLC
Franklin Resources Inc.
Adage Capital Partners GP L.L.C.
Boothbay Fund Management LLC
Price T Rowe Associates Inc. MD
Invesco Ltd.
Tang Capital Management LLC
Sphera Funds Management LTD.
Within the previous year, company insiders that have sold Applied Therapeutics company stock include:
Real Estate Equitie Alexandria (Major Shareholder)
Shoshana Shendelman (CEO)
Riccardo Perfetti (Insider)
Leslie D Funtleyder (Insider)
Leslie D Funtleyder (CFO)
Learn More investors selling Applied Therapeutics stock.
Which major investors are buying Applied Therapeutics stock?: In the previous quarter, APLT stock was acquired by institutional investors including:
Vestal Point Capital LP
Schonfeld Strategic Advisors LLC
T. Rowe Price Investment Management Inc.
Propel Bio Management LLC
Alyeska Investment Group L.P.
Millennium Management LLC
Marshall Wace LLP
Two Sigma Investments LP